| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000003608 |
| Receipt No. | R000004374 |
| Official scientific title of the study | Imaging study using positron emission tomography with AV-45 for dementia |
| Date of disclosure of the study information | 2010/05/12 |
| Last modified on | 2017/11/16 (Ver. 13) |
| Basic information | ||
| Official scientific title of the study | Imaging study using positron emission tomography with AV-45 for dementia | |
| Title of the study (Brief title) | Positron emission tomography for dementia | |
| Region |
|
|
| Condition | ||||
| Condition | dementia | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To investigate the distribution and deposits of beta-amyloid in brain using positron emission tomography and the correlation between the imaging data and cognitive function in Alzheimer's disease and mild cognitive impairment. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Amyloid deposits and distribution in brain measured by positron emission tomography among patients and age-matched normal controls. |
| Key secondary outcomes | To investigate the correlation between the cognitive function, brain MRI, and FDG-PET and amyloid deposits. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 5 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | PET, MRI, Neuropsychological test | |
| Interventions/Control_2 | PET, MRI, Neuropsychological test | |
| Interventions/Control_3 | PET, MRI, Neuropsychological test | |
| Interventions/Control_4 | PET, MRI, Neuropsychological test | |
| Interventions/Control_5 | PET, MRI, NEuropsychological test | |
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects who have the ability to provide informed consent and adhere to the protocol.
Normal controls: - Without past or current history of cognitive dysfunction - Mini-Mental State Exam score is 28 or more Alzheimer's disease: - Subject who meet the diagnostic criteria of Alzheimer's disease on International classification of Diseases 10th revision - Informed consents are obtained from patients and one of their family members Mild cognitive impairment: - Memory complaints by subject that is verified by a study partner - Objective cognitive impairment - General cognition and functional performance sufficiently preserved - Not meet the criteria of dementia Mental disorder with cognitive impairment Age-related macular degeneration |
|||
| Key exclusion criteria | Exclusion criteria:
- With past or current history of serious medical illness and/or brain organic diseases - Subject who is contraindicated for the use of MRI - With past or current history of severe liver disease, kidney disease, heart disease, allergy, or severe drug allergy - Subjects who are judged as not suitable for participation in this study |
|||
| Target sample size | 75 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshiro Okubo, M.D., Ph.D. |
| Organization | Nippon Medical School |
| Division name | Department of Neuropsychiatry |
| Address | 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan |
| TEL | 03-3822-2131 |
| okubo-y@nms.ac.jp | |
| Public contact | |
| Name of contact person | Amane Tateno, M.D., Ph.D. |
| Organization | Nippon Medical School |
| Division name | Department of Neuropsychiatry |
| Address | 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan |
| TEL | 03-3822-2131 |
| Homepage URL | |
| amtateno@nms.ac.jp | |
| Sponsor | |
| Institute | Nippon Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 日本医科大学付属病院健診医療センター、日本医科大学付属病院、メディカルサテライト八重洲クリニック神田分院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004374 |